SomaLogic proteomics reveals new biomarkers and provides mechanistic, clinical insights into Acetyl coA Carboxylase (ACC) inhibition in Non-alcoholic Steatohepatitis (NASH)

Abstract Non-alcoholic Fatty Liver Disease (NAFLD) and Non-alcoholic Steatohepatitis (NASH) are major metabolic diseases with increasing global prevalence and no approved therapies. There is a mounting need to develop biomarkers of diagnosis, prognosis and treatment response that can effectively rep...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Pitchumani Sivakumar, Michelle Saul, Douglas Robinson, Lindsay E. King, Neeta B. Amin
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Nature Portfolio 2024-07-01
Reeks:	Scientific Reports
Onderwerpen:	NAFLD/NASH Biomarkers Acetyl CoA Carboxylase Liver fibrosis SomaLogic proteomics
Online toegang:	https://doi.org/10.1038/s41598-024-67843-8
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!